About

About bioSeedin bioSeedin, one of the most preeminent asset management, public relations, and financial advisory firms for biotech and pharmaceutical companies. We operate across North America, Europe, and APAC. Based on hosting multiple annual conferences, which include the annual Biopharmaceutical Developer Innovation Conference (BDIC), the largest and most influential conference in APAC, and the investment and licensing conference DJseedin. bioSeedin aggregates industrial resources across 8000 pharmaceutical enterprises worldwide. We provide asset management services via licensing in and out, co-developmental partner sourcing, and project implementation, as well as advising on public relations management, Asia market entry, investment strategy, mergers and acquisitions, and capital raising. bioSeedin aims to be the supreme asset transaction platform for our global clients, by facilitating R&D efficiency, maximizing research resources and funding, and emerging market access to deliver therapeutics faster and benefit our patients worldwide. bioSeedin is a subsidiary of ACROBiosystems Group, a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business model innovation. About bioSeedin bioSeedin, one of the most preeminent asset management, public relations, and financial advisory firms for biotech and pharmaceutical companies. We operate across North America, Europe, and APAC. Based on hosting multiple annual conferences, which include the annual Biopharmaceutical Developer Innovation Conference (BDIC), the largest and most influential conference in APAC, and the investment and licensing conference DJseedin. bioSeedin aggregates industrial resources across 8000 pharmaceutical enterprises worldwide. We provide asset management services via licensing in and out, co-developmental partner sourcing, and project implementation, as well as advising on public relations management, Asia market entry, investment strategy, mergers and acquisitions, and capital raising. bioSeedin aims to be the supreme asset transaction platform for our global clients, by facilitating R&D efficiency, maximizing research resources and funding, and emerging market access to deliver therapeutics faster and benefit our patients worldwide. bioSeedin is a subsidiary of ACROBiosystems Group, a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business model innovation. bioSeedin, one of the most preeminent asset management, public relations, and financial advisory firms for biotech and pharmaceutical companies, which operates across North America, Europe, and Asia. Based on hosting the annual BIOseedin licensing and investment partnering conference and Biopharmaceutical Developer Innovation Conference (BDIC), the largest and most influential conference in Asia, bioSeedin aggregates industrial resources across 8000 pharmaceutical enterprises worldwide. The firm supports asset management via licensing in and out, co-developmental partner sourcing, and project implementation, as well as advising on public relations management. bioSeedin aims to be the supreme asset transaction platform for our global clients. By facilitating R&D efficiency, maximizing research resources and funding, and emerging market access to deliver therapeutics faster and benefit our patients worldwide. Our antibody and VHH nanobody sequence licensing platform aims to be the best resource for early-stage therapeutic development in ADC, bi-specific antibody, and cell therapeutic fields.